| Evolution of the average Target Price on PFIZER, INC. |
|
|
|
| Target Price consensus revisions : last 18 months |
|
|
|
|
|
|
AstraZeneca : GSK to boost spending power of pharma business post break-up |
| Mean consensus |
HOLD |
| Number of Analysts |
24 |
| Last Close Price |
39,61 $ |
| Average target price |
42,34 $ |
| Spread / Average Target |
6,89% |
| Objectif de cours Haut |
53,00 $ |
| Spread / Highest target |
33,8% |
| Objectif de cours Bas |
36,00 $ |
| Spread / Lowest Target |
-9,11% |
Consensus revision (last 18 months)
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
